Phase 2 Clostridioides Difficile Infection Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Clostridioides Difficile Infection
AstraZeneca230 enrolled114 locationsNCT07285213
Recruiting
Phase 1Phase 2
Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients
Clostridioides Difficile InfectionRecurrent Infection
Hospices Civils de Lyon56 enrolled9 locationsNCT06306014
Recruiting
Phase 2Phase 3
LMN-201 for Prevention of C. Difficile Infection Recurrence
Clostridioides Difficile Infection
Lumen Bioscience, Inc.375 enrolled16 locationsNCT05330182
Recruiting
Phase 2Phase 3
Secondary Prevention of Clostridioides Difficile Using Vancomycin
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre300 enrolled1 locationNCT06979609
Recruiting
Phase 2
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Clostridium Difficile InfectionClostridioides Difficile InfectionClostridium Difficile Diarrhea+1 more
University of Virginia260 enrolled2 locationsNCT04305769